Literature DB >> 11694375

Voice outcome following thyroplasty in patients with cancer-related vocal fold paralysis.

C R Billante1, B Spector, M Hudson, K Burkard, J L Netterville.   

Abstract

Medialization laryngoplasty restores voice in patients with unilateral laryngeal paralysis. Of question was whether patients with vocal fold paralysis resulting from cancer or its treatment had as good a post-operative voice result as patients with vocal fold paralysis of benign etiology. The purpose of the present study was to compare post-operative perceptual, acoustic, aerodynamic, and quality of life data in these two patient groups. Twenty-eight patients with vocal fold paralysis secondary to malignancy or its treatment were age and gender-matched with patients with paralysis resulting from benign origin. Pre- and post-operative perceptual judgments of pitch, loudness and quality were rated independently by two speech-language pathologists. A digital audiotape of the patient's voice was analyzed using Soundscope software. Fundamental frequency, conversational intensity and perturbation were evaluated. Glottal flow rates in propositional speech, phonation times and extent of pitch and loudness ranges were also measured. Three quality of life surveys, the Short Form-36 general health survey, the Voice Handicap Index, and the Voice Outcomes Study were administered. Results of voice testing indicated that perceptual, acoustic and aerodynamic data were significantly improved 3 months after thyroplasty in all patients regardless of whether they had a history of cancer. Quality of life data, however, distinguished the two groups. In particular, the general health measure found a significant difference in physical functioning and overall vitality, although satisfaction with improved voice was equally appreciated in both patient groups. Of clinical significance is that though general health may differ, patients with cancer-related laryngeal paralysis can expect to have as good a voice outcome following thyroplasty as patients with paralysis of benign etiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694375     DOI: 10.1016/s0385-8146(01)00101-8

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  7 in total

1.  Voice handicap index and voice-related quality of life in small laryngeal carcinoma.

Authors:  C Kasper; M Schuster; G Psychogios; J Zenk; A Ströbele; F Rosanowski; E Grässel; T Haderlein
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-07       Impact factor: 2.503

2.  [Grading of the Voice Handicap Index].

Authors:  E Grässel; U Hoppe; F Rosanowski
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

3.  [Determination of subjective impairment in dysphonia. A methodological comparison].

Authors:  S Günther; T Rasch; M Klotz; U Hoppe; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

4.  Addressing an unmet need in oncology patients: rehabilitation of upper aerodigestive tract function.

Authors:  M E Kupferman; J Acevedo; K A Hutcheson; J S Lewin
Journal:  Ann Oncol       Date:  2011-02-14       Impact factor: 32.976

5.  Neuromonitoring in thyroidectomy: a meta-analysis of effectiveness from randomized controlled trials.

Authors:  Alvaro Sanabria; Adonis Ramirez; Luiz P Kowalski; Carl E Silver; Ashok R Shaha; Randall P Owen; Carlos Suárez; Avi Khafif; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-17       Impact factor: 2.503

6.  [Voice handicap in patients with organic and functional dysphonia].

Authors:  S Weigelt; S Krischke; M Klotz; U Hoppe; V Köllner; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

7.  Voice handicap Index evaluation in patients with moderate to profound bilateral sensorineural hearing loss.

Authors:  Felipe Barbosa Madeira; Shiro Tomita
Journal:  Braz J Otorhinolaryngol       Date:  2010 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.